| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.39▼ | 1.38▼ | 1.39▼ | 1.40▼ | 1.35▲ |
| MA10 | 1.38▼ | 1.39▼ | 1.39▼ | 1.39▼ | 1.29▲ |
| MA20 | 1.38▼ | 1.40▼ | 1.41▼ | 1.34▲ | 1.38▲ |
| MA50 | 1.41▼ | 1.40▼ | 1.39▼ | 1.29▲ | 1.27▲ |
| MA100 | 1.39▼ | 1.39▼ | 1.36▲ | 1.36▲ | 1.19▲ |
| MA200 | 1.39▼ | 1.32▲ | 1.27▲ | 1.23▲ | 26,513.86▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.002▼ | -0.007▼ | 0.006▲ | 0.233▲ |
| RSI | 45.346▼ | 45.431▼ | 46.235▼ | 54.515▲ | 33.914▼ |
| STOCH | 27.778 | 37.619 | 18.948▼ | 48.454 | 51.236 |
| WILL %R | -71.429 | -80.000▼ | -87.500▼ | -57.085 | -57.116 |
| CCI | -58.333 | -50.629 | -79.492 | -3.252 | 8.887 |
|
Wednesday, August 05, 2026 02:00 PM
Insurance giant Allstate (NYSE:ALL) reported Q2 CY2026 results , with sales up 10.8% year on year to $18.6 billion. Its non-GAAP profit of $8.99 per share was 48% above analysts’ consensus estimates.
|
|
Thursday, June 18, 2026 05:01 AM
TARPON SPRINGS, Fla., June 18, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib ...
|
|
Friday, May 08, 2026 05:45 AM
TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/08/26 | 1.38 | 1.405 | 1.37 | 1.38 | 29,388 |
| 21/08/26 | 1.41 | 1.4919 | 1.38 | 1.42 | 111,233 |
| 20/08/26 | 1.41 | 1.49 | 1.39 | 1.43 | 77,629 |
| 19/08/26 | 1.35 | 1.49 | 1.35 | 1.43 | 114,476 |
| 18/08/26 | 1.36 | 1.36 | 1.2522 | 1.35 | 51,380 |
| 17/08/26 | 1.39 | 1.39 | 1.325 | 1.34 | 54,834 |
| 14/08/26 | 1.41 | 1.41 | 1.35 | 1.37 | 45,332 |
| 13/08/26 | 1.42 | 1.43 | 1.255 | 1.36 | 150,744 |
| 12/08/26 | 1.46 | 1.46 | 1.36 | 1.40 | 63,408 |
| 11/08/26 | 1.43 | 1.55 | 1.3701 | 1.43 | 127,501 |
|
|
||||
|
|
||||
|
|